Preventing ovarian hyperstimulation syndrome: Cabergoline versus coasting

Archives of Gynecology and Obstetrics

Volumn 288, Issue 5, 2013, Pages 1159-1163

  Esinler, Ibrahim ^a   Bozdag, Gurkan ^a   Karakocsokmensuer, Lale ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cabergoline; Coasting; ICSI; IVF; OHSS; Ovarian hyperstimulation syndrome

Indexed keywords

CABERGOLINE; CHORIONIC GONADOTROPIN; ETHINYLESTRADIOL PLUS NORGESTREL; GONADORELIN AGONIST; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

AGE; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; COASTING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY HYPERSTIMULATION; OVULATION INHIBITION; PREGNANCY RATE; RISK REDUCTION; SPONTANEOUS ABORTION;

ADULT; DOPAMINE AGONISTS; ERGOLINES; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INFERTILITY, FEMALE; LEUPROLIDE; LONGITUDINAL STUDIES; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84886088893     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2875-z     Document Type: Article

References (25)

1. Aboulghar M (2009) Symposium: update on prediction and management of OHSS. Prevention of OHSS. Reprod Biomed Online 19:33-42
2. Aboulghar M, Evers JH, Al-Inany H (2002) Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review. Hum Reprod 17:3027-3032
3. Al-Shawaf T, Zosmer A, Hussain S et al (2001) Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Hum Reprod 16:24-30
4. Alvarez C, Alonso-Muriel I, Garcia G et al (2007) Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 22:3210-3214
5. Alvarez C, Marti-Bonmati L, Novella-Maestre E et al (2007) Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92:2931-2937
6. Barash A, Weissman A, Manor M et al (1998) Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil Steril 69:496-499
7. Bukulmez O, Yarali H, Yucel A et al (2000) Intracytoplasmic sperm injection versus in vitro fertilization for patients with a tubal factor as their sole cause of infertility: a prospective, randomized trial. Fertil Steril 73:38-42
8. Carizza C, Abdelmassih V, Abdelmassih S et al (2008) Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod Biomed Online 17:751-755
9. Egbase PE, Sharhan MA, Grudzinskas JG (1999) Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum Reprod 14:1421-1425
10. Faul F, Erdfelder E, Buchner A et al (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149-1160
11. Garcia-Velasco JA, Isaza V, Quea G et al (2006) Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril 85:547-554
12. Garcia-Velasco JA, Pellicer A (2003) New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr Opin Obstet Gynecol 15:251-256
13. Hwang JL, Lin YH, Seow KM (2010) Failure of cabergoline to prevent severe ovarian hyperstimulation syndrome in patients with extremely high estradiol levels. Int J Gynaecol Obstet 108:159-160
14. Kol S, Solt I (2008) GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? J Assist Reprod Genet 25:63-66
15. Ludwig M, Bauer O, Lopens A et al (1998) Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 13:30-32
16. Mansour R, Aboulghar M, Serour G et al (2005) Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 20:3167-3172
17. Nargund G, Hutchison L, Scaramuzzi R et al (2007) Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reprod Biomed Online 14:682-685
18. Rimington MR, Walker SM, Shaw RW (1997) The use of laparoscopic ovarian electrocautery in preventing cancellation of in vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries. Hum Reprod 12:1443-1447
19. Rizk B, Aboulghar M, Smitz J et al (1997) The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update 3:255-266
20. Sher G, Zouves C, Feinman M et al (1995) 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization. Hum Reprod 10:3107-3109
21. Sohrabvand F, Ansaripour S, Bagheri M et al (2009) Cabergoline versus coasting in the prevention of ovarian hyperstimulation syndrome and assisted reproductive technologies outcome in high risk patients. Int J Fertil Steril 3:35-40
22. Tang H, Hunter T, Hu Y et al (2012) Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2:CD008605
23. Ulug U, Bahceci M, Erden HF et al (2002) The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod 17:310-313
24. Waldenstrom U, Kahn J, Marsk L et al (1999) High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study. Hum Reprod 14:294-297
25. Youssef MA, van Wely M, Hassan MA et al (2010) Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis. Hum Reprod Update 16:459-466